Clinical Trial

The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 8, 2025 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
The study will include participants who were diagnosed with inflammatory disease and followed up at National Taiwan University Children's Hospital. The investigators will check the NUDT15 gene test, if the participant agrees to do an additional blood test. The result of the gene test will be analyzed and compared with other clinical data.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-30.
Trial Details
NCT Number NCT06913998
Lead Sponsor National Taiwan University Hospital
Conditions Inflammatory Bowel Diseases, Neutropenia, Nudt15 Deficiency
Enrollment 65 participants
Start Date 2023-12-27
Primary Completion 2026-01 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2025-04-08